Governor Baker Tours Ashland’s MatTek Life Sciences, Pivoting to COVID-19 Research, Funded by M-ERT
Governor Baker Tours Ashland’s MatTek Life Sciences, Pivoting to COVID-19 Research, Funded by M-ERT
Broad Institute launches academic-industry cell imaging consortium to speed drug discovery and development
The Imaging Platform at the Broad Institute of MIT and Harvard, together with industry and non-profit partners, has launched a new collaboration to create a massive cell-imaging dataset, displaying more...
Read MoreInterns Playing a Vital Role in a Pandemic
Massachusetts is home to countless life sciences companies working to accelerate the commercialization of promising treatments, therapies, and cures that will improve patient care. Kephera Diagnostics is one of these...
Read MoreMassachusetts manufacturers respond to COVID-19
The Manufacturing Emergency Response Team (M-ERT) is a coordinated response by the Baker-Polito Administration and leading academic and industry stakeholders to support the Commonwealth’s manufacturers in their efforts to produce...
Read MoreFDA and Health Canada approve Thermedical’s Degassed Saline to help reduce risk of stroke
Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied...
Read MoreAkili announces FDA clearance of EndeavorRx™ for children with ADHD
Akili Interactive announced this week that the FDA has granted clearance for the company’s EndeavorRx as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Delivered through a captivating video...
Read MoreDamon Cox Named New Interim President and CEO of the MLSC
The Massachusetts Life Sciences Center (MLSC), with support from the Executive Office of Housing and Economic Development (EOHED), continues a robust search process for a permanent President and Chief Executive...
Read MoreModerna advances late-stage development of its vaccine against COVID-19
Moderna, Inc. announced progress on late-stage development of mRNA-1273, the company’s mRNA vaccine candidate against COVID-19. Moderna has finalized the Phase 3 study protocol based on feedback from the U.S....
Read MoreMIT plays key role in statewide effort to produce PPE
Across the Massachusetts Emergency Response Team (M-ERT) operations, MIT students, faculty, staff, and alumni can be found lending their support to the efforts. In some cases, community members are working...
Read More